1. Hijazi, Hadia, Reis, Linda M, Pehlivan, Davut, Semina, Elena V, Lupski, James R. 2022. TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions. In American journal of human genetics, 109, 2270-2282. doi:10.1016/j.ajhg.2022.10.007. https://pubmed.ncbi.nlm.nih.gov/36368327/
2. Pillutla, R C, Shimamoto, A, Furuichi, Y, Shatkin, A J. . Genomic structure and chromosomal localization of TCEAL1, a human gene encoding the nuclear phosphoprotein p21/SIIR. In Genomics, 56, 217-20. doi:. https://pubmed.ncbi.nlm.nih.gov/10051408/
3. Rushworth, Linda K, Harle, Victoria, Repiscak, Peter, Leung, Hing Y, Patel, Rachana. 2020. In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer. In Life science alliance, 3, . doi:10.26508/lsa.202000770. https://pubmed.ncbi.nlm.nih.gov/33033111/
4. Makino, H, Tajiri, T, Miyashita, M, Johnston, J, Gabrielson, E. . Differential expression of TCEAL1 in esophageal cancers by custom cDNA microarray analysis. In Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 18, 37-40. doi:. https://pubmed.ncbi.nlm.nih.gov/15773840/
5. Boyero, Laura, Noguera-Uclés, José Francisco, Castillo-Peña, Alejandro, Paz-Ares, Luis, Molina-Pinelo, Sonia. 2023. Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer. In Cancers, 15, . doi:10.3390/cancers15051466. https://pubmed.ncbi.nlm.nih.gov/36900258/
智鼠故事 
